Business Context and Reporting Period
EUDA Health Holdings Limited, a foreign private issuer, furnished this Form 6-K for July 2023. The filing reports a Nasdaq continued-listing deficiency notice received on July 31, 2023; the Form 6-K was signed on August 2, 2023.
Financial and Liquidity Information
The filing does not provide revenue, profit, cash flow, margin, debt, cash balance, or liquidity figures.
Nasdaq stated that the Company did not meet the minimum $2.5 million stockholders’ equity requirement under Listing Rule 5550(b)(1) or the minimum $500,000 net income from continuing operations requirement under Listing Rule 5550(b)(3). The filing does not provide the Company’s specific stockholders’ equity or net income amounts.
Material Changes and Listing Compliance
- Nasdaq notified EUDA that its market value of listed securities had remained below $35 million for the preceding 30 consecutive business days, violating Listing Rule 5550(b)(2).
- The notice had no immediate effect on the Nasdaq listing.
- EUDA received 180 calendar days, through January 24, 2024, to regain compliance with the market-value requirement.
- To regain compliance under Rule 5550(b)(2), the Company’s market value of listed securities must close at or above $35 million for at least 10 consecutive business days during the compliance period.
- The Company also did not meet the equity and net-income continued-listing standards described above.
Outlook, Risks, and Contingencies
Management stated that the Company intends to consider available options to resolve the Nasdaq deficiencies. However, the filing provides no specific remediation plan and gives no assurance that compliance will be regained.
If EUDA does not regain compliance with the applicable requirements, Nasdaq may issue a delisting notice. The Company may appeal a delisting determination, but there is no assurance that Nasdaq would permit continued listing. Delisting could materially reduce the liquidity and marketability of the Company’s securities.
Important Facts for Investors to Verify
- Whether EUDA regained compliance with the $35 million market-value requirement by January 24, 2024.
- Whether the Company satisfied the $2.5 million stockholders’ equity and $500,000 net-income requirements.
- Any subsequent Nasdaq extension, hearing, appeal, delisting determination, or other listing action.
- The Company’s actual financial condition, including equity, profitability, cash resources, debt, and liquidity, which are not provided in this filing.